Theravance Biopharma (TBPH)
(Real Time Quote from BATS)
$8.58 USD
+0.05 (0.59%)
Updated Jun 4, 2024 12:18 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Brokerage Reports
Theravance Biopharma, Inc. [TBPH]
Reports for Purchase
Showing records 1 - 20 ( 208 total )
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Yupelri''s Sales Continue to Grow; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
PIFR-2 Study Result was Disappointing, We See Plenty of Runway for Yupelri; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for TBPH 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Company: Theravance Biopharma, Inc.
Industry: Medical - Drugs
Yupelri Continues To Chug Along as Theravance Approaches Profitability; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D